Wockhardt Ltd. (WOCKPHARMA): Wockhardt Share Price rises 2.41% as stock gains today
- September 22, 2026
- Posted by: Harsh Piplani
- Category: News
Wockhardt Share Price is Rs 2,240.35 today, up 2.41%, with market capitalisation at Rs 33,911.3 crore. The move is notable, but the supplied data does not establish a company-specific catalyst.
Wockhardt Share Price is in focus after the stock rose 2.41% to Rs 2,240.35 from the previous close of Rs 2,187.65, with the company valued at Rs 33,911.3 crore. The day’s move has placed Wockhardt Ltd. among the stocks in news on the Indian stock market, even though the supplied data does not establish a company-specific reason for the gain.
For investors tracking Wockhardt Share Price Today, the main facts are straightforward: the stock opened at Rs 2,201.20, touched an intraday high of Rs 2,248.25 and a low of Rs 2,199.00, while turnover stood at Rs 6.77 crore. Univest is covering the move as a price rise event, not as a confirmed event-driven rerating. The latest Wockhardt Stock News therefore sits around observed price action, valuation and sector context rather than a stated trigger.
That makes the Wockhardt Share Price update useful for readers asking why Wockhardt is rising today. The verified data confirms the share price rise, but it does not identify a corporate announcement or other catalyst. In this note, Univest focuses on what can be checked directly: the day’s move, the company’s valuation, profitability profile, industry benchmark and peer positioning.
Wockhardt Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,240.35 |
| Previous Close | Rs 2,187.65 |
| Today's Move | Rs 52.7 (+2.41%) |
| Open | Rs 2,201.2 |
| High | Rs 2,248.25 |
| Low | Rs 2,199 |
| Turnover | Rs 6.77 crore |
| Market Capitalisation | Rs 33,911.3 crore |
| Market Cap Category | Large Cap |
Wockhardt Ltd. (WOCKPHARMA) rose to Rs 2,240.35 from the previous close of Rs 2,187.65, a move of Rs 52.7 or 2.41%. The stock opened at Rs 2,201.2, reached a high of Rs 2,248.25, recorded a low of Rs 2,199.
Wockhardt Share Price today reflects a Rs 52.70 gain over the previous close, with the stock moving from Rs 2,187.65 to Rs 2,240.35. The day’s range ran from Rs 2,199.00 to Rs 2,248.25, which shows the stock stayed close to the upper part of its session range. On the available numbers, this is a clean same-day price rise rather than a broader trend statement.
For readers following Wockhardt Share Price Live, the important market facts are the current price, the 2.41% change and turnover of Rs 6.77 crore. Wockhardt Stock Gaining Today is therefore best read as a factual description of the session, not as proof of any underlying news flow. Wockhardt Share Price News on the day is about the observed movement itself.
In practical terms, this Wockhardt Share Price update shows a positive session with a modestly wider intraday spread between the day’s low and high. Univest flags such moves because they often become search-interest events, even when the immediate cause is not supplied in the data.
Wockhardt Ltd. (WOCKPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 33,911.3 crore |
| P/E Ratio | 86.91x |
| P/B Ratio | 7.06x |
| ROE | 4.29% |
| ROCE | 6.79% |
| EPS | Rs 25.17 |
| Book Value Per Share | Rs 309.81 |
| Dividend Yield | 0% |
Wockhardt Ltd. (WOCKPHARMA) fundamental metrics show P/E 86.91x, P/B 7.06x, ROE 4.29%, ROCE 6.79%. These figures provide context only and are not a buy or sell signal.
Wockhardt Ltd. has a market capitalisation of Rs 33911.3 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 86.91x, P/B at 7.06x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.29% and ROCE of 6.79%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 25.17, book value per share of Rs 309.81, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.62x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 86.91x |
| Benchmark Median P/E | 32.62x |
| Benchmark Average P/E | 49.51x |
| Benchmark P/E Range | 3.37x to 747.32x |
| Company P/B Ratio | 7.06x |
| Benchmark Median P/B | 3x |
| Company ROE | 4.29% |
| Benchmark Median ROE | 11.74% |
| Company ROCE | 6.79% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 33,911.3 crore |
| Benchmark Median Market Cap | Rs 746.45 crore |
Wockhardt Ltd. (WOCKPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 86.91x, which is above the benchmark median of 32.62x, a difference of +166.43%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Wockhardt Ltd. (WOCKPHARMA) has a ROE of 4.29%, which is below the benchmark median of 11.74%, a difference of -63.46%. Wockhardt Ltd. (WOCKPHARMA) has a ROCE of 6.79%, which is below the benchmark median of 13.63%, a difference of -50.18%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 37.05 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.6 | 14.18 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 86.64 | 21.05 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.67 | 4.3 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 33.19 | 3.18 | 11.83 | 16 |
Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 86.91x compared with the displayed peer median of 37.05x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.29% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 6.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Wockhardt Ltd. (WOCKPHARMA) has a market capitalisation of Rs 33,911.3 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Wockhardt
- Wockhardt Share Price rose 2.41% today to Rs 2,240.35, after closing at Rs 2,187.65 previously.
- The day’s high was Rs 2,248.25 and the low was Rs 2,199.00, showing the session’s price range.
- Market capitalisation stands at Rs 33,911.3 crore, which places the company well above the industry median in the supplied set.
- P/E is 86.91 and P/B is 7.06, both above the benchmark medians of 32.62 and 3.00 in the same industry sample.
- ROE of 4.29% and ROCE of 6.79% are below the sector medians, which adds valuation context to the Wockhardt Share Price move.
About Wockhardt
Wockhardt Ltd. is part of the Healthcare sector and operates in the Pharmaceuticals & Drugs industry. The company is followed through its NSE and BSE listings under the symbol WOCKPHARMA, and its market capitalisation currently stands at Rs 33,911.3 crore. The supplied data does not include a business-segment breakdown, so this overview stays focused on the verified company profile.
For readers searching Wockhardt Company News or Wockhardt Latest News, the relevant context is the company’s position within a large pharma peer set and its valuation profile. Wockhardt Share Price therefore reflects a listed pharma company whose market value is materially higher than the industry median, while its profitability ratios are below the benchmark central tendency. Univest presents that context without adding claims that are not supported by the data.
Track Wockhardt Share Price on Univest
Use Wockhardt Ltd. (WOCKPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors who want to follow Wockhardt Share Price Today can track live share price updates, market cap, fundamental ratios, shareholding pattern, sector context and 52-week levels on Univest. The platform also helps readers review Wockhardt Stock Analysis, Wockhardt Fundamental Analysis and Wockhardt Share News in one place.
That makes it easier to study Wockhardt Share Price Live alongside related market insights without relying on guesswork.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Wockhardt Share Price rising today?
Ans. The supplied data confirms that Wockhardt Share Price rose 2.41% today, but it does not establish a company-specific catalyst. The move is therefore best treated as verified price action, not as a explained news event.
What is Wockhardt Share Price today?
Ans. Wockhardt Share Price is Rs 2,240.35, compared with the previous close of Rs 2,187.65. The stock gained Rs 52.70 during the session, which equals a 2.41% rise on the day.
What is Wockhardt market cap?
Ans. Wockhardt’s market capitalisation is Rs 33,911.3 crore. That places the company above the industry median in the supplied healthcare benchmark, making its current valuation context important for Wockhardt Share Price readers.
How does Wockhardt compare with pharma peers?
Ans. Wockhardt’s P/E of 86.91 is above several peers such as Sun Pharma, Zydus Lifesciences and Cipla. Its ROE of 4.29% and ROCE of 6.79% are lower than the stronger peer figures supplied.
Is Wockhardt expensive on valuation metrics?
Ans. Relative to the supplied industry benchmark, Wockhardt looks expensive on P/E and P/B because both are above the sector medians and averages. That view is based on the provided numbers, not a forecast.
What do Wockhardt EPS and book value show?
Ans. Wockhardt EPS is Rs 25.17 and book value is Rs 309.81 per share. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.
Where can I track Wockhardt Share Price on Univest?
Ans. You can track Wockhardt Share Price, live updates, market cap, ratios and sector context on Univest. The platform also brings together Wockhardt Stock News, valuation checks and company overview data in one place.
